{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:02:46Z","timestamp":1785330166352,"version":"3.55.0"},"reference-count":25,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/21645515.2026.2707019","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:03:19Z","timestamp":1784912599000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Passive surveillance of adverse events following immunization for National Immunization Program vaccines in Shenyang, China, 2009\u20132024"],"prefix":"10.1080","volume":"22","author":[{"given":"Nina","family":"Jia","sequence":"first","affiliation":[{"name":"Shenyang Center for Disease Control and Prevention","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhong","sequence":"additional","affiliation":[{"name":"Liaoning Provincial Center for Disease Control and Prevention","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Gao","sequence":"additional","affiliation":[{"name":"Shenyang Center for Disease Control and Prevention","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhu","sequence":"additional","affiliation":[{"name":"Shenyang Center for Disease Control and Prevention","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanyi","family":"Li","sequence":"additional","affiliation":[{"name":"Shenyang Center for Disease Control and Prevention","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(22)00171-2"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.07.041"},{"key":"e_1_3_4_4_1","volume-title":"Global manual on surveillance of adverse events following immunization[M]","author":"WHO","year":"2016","unstructured":"WHO. Global manual on surveillance of adverse events following immunization[M]. Geneva, Switzerland: WHO Document Production Services; 2016."},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.04.060"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2035141"},{"key":"e_1_3_4_7_1","volume-title":"National guideline for surveillance of adverse events following immunization[S]","author":"General Office of Ministry of Health, General Office of State Food and Drug Administration","year":"2010","unstructured":"General Office of Ministry of Health, General Office of State Food and Drug Administration. National guideline for surveillance of adverse events following immunization[S]. Beijing: Ministry of Health of the People\u2019s Republic of China; 2010 Jun 10."},{"issue":"1","key":"e_1_3_4_8_1","first-page":"9","article-title":"Surveillance of adverse events following immunization in China, 2017","volume":"26","author":"Li KL","year":"2019","unstructured":"Li KL, Zhang L, Ye JK, Zheng J, Cao L, Wang H. Surveillance of adverse events following immunization in China, 2017. Chin J Vaccines Immun. 2019;26(1):9\u201318.","journal-title":"Chin J Vaccines Immun"},{"issue":"6","key":"e_1_3_4_9_1","first-page":"80","article-title":"Analysis of suspected adverse events following immunization monitoring in Fengtai District, Beijing, 2010\u20132020","volume":"36","author":"Lan B","year":"2022","unstructured":"Lan B, Jiang XF, Meng FC, Tang T. Analysis of suspected adverse events following immunization monitoring in Fengtai District, Beijing, 2010\u20132020. Primary Health Care China. 2022;36(6):80\u201383.","journal-title":"Primary Health Care China"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.33321\/cdi.2019.43.29"},{"key":"e_1_3_4_11_1","unstructured":"Agenzia Italiana del Farmaco (AIFA). Italian vaccines report 2017[EB\/OL]. 2018. [accessed 2020 Mar 14]. http:\/\/www.aifa.gov.it\/sites\/default\/files\/Rapporto_Vaccini_2017_vers._acc.pdf."},{"issue":"12","key":"e_1_3_4_12_1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.14745\/ccdr.v44i12a04","article-title":"Vaccine safety surveillance in Canada: reports to CAEFISS, 2017","volume":"44","author":"Johnson K","year":"2018","unstructured":"Johnson K, Anyoti H, Coulby C. Vaccine safety surveillance in Canada: reports to CAEFISS, 2017. Can Commun Dis Rep. 2018;44(12):324\u2013330.","journal-title":"Can Commun Dis Rep"},{"issue":"4","key":"e_1_3_4_13_1","first-page":"438","article-title":"Surveillance of adverse events following immunization in China, 2019","volume":"27","author":"Zhang LN","year":"2021","unstructured":"Zhang LN, Li KL, Du W, Li Y, Fan CX, Yu WZ, Cao L, Cao L, Yin Z. Surveillance of adverse events following immunization in China, 2019. Chin J Vaccines Immun. 2021;27(4):438\u2013445.","journal-title":"Chin J Vaccines Immun"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.4067\/S0716-10182019000400461"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00948"},{"issue":"3","key":"e_1_3_4_16_1","first-page":"299","article-title":"Adverse events following immunization in China, 2016","volume":"24","author":"Xu DS","year":"2018","unstructured":"Xu DS, Li KL, Wu WD. Adverse events following immunization in China, 2016. Chin J Vaccines Immun. 2018;24(3):299\u2013309, 322.","journal-title":"Chin J Vaccines Immun"},{"key":"e_1_3_4_17_1","unstructured":"WHO. Vaccine reaction rates information sheets on measles mumps and rubella vaccines[EB\/OL]. 2014-05. [accessed 2021 Jan 20]. https:\/\/www.who.int\/publications\/m\/item\/mmr-vaccine-rates-information-sheet."},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.07.048"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.04.036"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01790.x"},{"issue":"3","key":"e_1_3_4_21_1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/adc.84.3.227","article-title":"Idiopathic thrombocytopenic purpura and MMR vaccine","volume":"84","author":"Miller E","year":"2001","unstructured":"Miller E, Waight P, Farrington CP, Andrews N, Stowe J, Taylor B. Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child. 2001;84(3):227\u2013229.","journal-title":"Arch Dis Child"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.23601"},{"key":"e_1_3_4_23_1","unstructured":"WHO. Vaccine reaction rates information sheets on bacillus Calmette-Gu\u00e9rin[EB\/OL]. 2012-04. [accessed 2020 Mar 15]. https:\/\/www.who.int\/vaccine_safety\/initiative\/tools\/BCG_Vaccine_rates_information_sheet.pdf."},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.01.038"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.05.056"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806113382403"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2026.2707019","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21645515.2026.2707019","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2026.2707019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T12:19:10Z","timestamp":1785327550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2026.2707019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/21645515.2026.2707019"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2026.2707019","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-03-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2707019"}}